NCT05478707View on ClinicalTrials.gov

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Diabetes Mellitus, Type 1Endothelial Dysfunction
Interventions
DRUG

Dulaglutide

GLP1-RA

DRUG

Placebo

Saline placebo

BEHAVIORAL

exercise training

supervised high intensity interval training

Trial Locations (1)

22908

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER